Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

Videos | Renal Denervation

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to ...

Home April 03, 2014
Home
News

March 27, 2014 — Scientists at CBSET, a not-for-profit preclinical research institute dedicated to biomedical research ...

Home March 27, 2014
Home
Blog

By Dave Fornell, DAIC editor


Data from several cutting-edge device clinical trials will be presented as late-breakers ...

Home March 25, 2014
Home
News
February 7, 2014 — Results from several late-breaking clinical trials will be presented during  the American College of ...
Home February 07, 2014
Home
News
January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant hypert ...
Home January 28, 2014
Home
News
January 10, 2014 — CVRx Inc. announced findings from a health-economic analysis published in the Journal of Hypertension ...
Home January 10, 2014
Home
Medtronic, symplicity, renal denervation
Feature
January 9, 2014 — Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat ...
Home January 09, 2014
Home
News
January 2, 2014 — Medtronic Inc. announced that the first patients were randomized in Symplicity HTN-4, which will ...
Home January 02, 2014
Home
acc pharmaceuticals renal denervation heart valve repair antiplatelet therapy
Feature
December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
Home December 24, 2013
Home
medtronic symplicity spyral renal denervation cath lab hypertension treatment G3
Feature
December 6, 2013 — Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in ...
Home December 06, 2013
Home
News

December 6, 2013 – Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running ...

Home December 06, 2013
Home
renal stenting
Feature | Dave Fornell
The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in ...
Home November 19, 2013
Home
News
November 13, 2013 — Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month ...
Home November 13, 2013
Home
renal denervation clinical trial study hypertension cath medtronic symplicity
Feature
November 13, 2013 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an ...
Home November 13, 2013
Home
News
November 8, 2013 — A new way of using blood pressure-lowering medications could prevent more than a fourth of heart ...
Home November 08, 2013
Home
Subscribe Now